Hypersensitivity Reactions to Obinutuzumab in Cynomolgus Monkeys and Relevance to Humans.

about

Hypersensitivity Reactions to Obinutuzumab in Cynomolgus Monkeys and Relevance to Humans.

Item

http://www.wikidata.org/entity/Q46317826

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Hypersensitivity Reactions to Obinutuzumab in Cynomolgus Monkeys and Relevance to Humans.

@en

Hypersensitivity Reactions to Obinutuzumab in Cynomolgus Monkeys and Relevance to Humans.

@nl

type

Item

label

Hypersensitivity Reactions to Obinutuzumab in Cynomolgus Monkeys and Relevance to Humans.

@en

Hypersensitivity Reactions to Obinutuzumab in Cynomolgus Monkeys and Relevance to Humans.

@nl

prefLabel

Hypersensitivity Reactions to Obinutuzumab in Cynomolgus Monkeys and Relevance to Humans.

@en

Hypersensitivity Reactions to Obinutuzumab in Cynomolgus Monkeys and Relevance to Humans.

@nl

P1476

Hypersensitivity Reactions to Obinutuzumab in Cynomolgus Monkeys and Relevance to Humans.

@en

P2093

Eginhard Schick

http://www.w3.org/2001/XMLSchema#string

Elisabeth Husar

http://www.w3.org/2001/XMLSchema#string

Gaurav Tyagi

http://www.w3.org/2001/XMLSchema#string

Hanna Piper-Lepoutre

http://www.w3.org/2001/XMLSchema#string

Maria Solonets

http://www.w3.org/2001/XMLSchema#string

Olaf Kuhlmann

http://www.w3.org/2001/XMLSchema#string

Thomas Singer

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization, biomarkers, and reversibility of a monoclonal antibody-induced immune complex disease in cynomolgus monkeys (Macaca fascicularis).

Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell-mediated B-cell cytotoxicity

CD20 antibodies: doing the time warp.

Rituximab infusion induces NK activation in lymphoma patients with the high-affinity CD16 polymorphism.

Immunogenicity of engineered antibodies.

Molecular bases of immune complex pathology.

Obinutuzumab-mediated high-affinity ligation of FcγRIIIA/CD16 primes NK cells for IFNγ production.

Immunogenicity of therapeutic proteins: the use of animal models.

Formation, clearance, deposition, pathogenicity, and identification of biopharmaceutical-related immune complexes: review and case studies.

The carbohydrate at FcgammaRIIIa Asn-162. An element required for high affinity binding to non-fucosylated IgG glycoforms.

P304

676-686

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0192623317723539

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28830332

http://www.w3.org/2001/XMLSchema#string